Correlation Between Procter Gamble and ACGCAP
Specify exactly 2 symbols:
By analyzing existing cross correlation between Procter Gamble and ACGCAP 195 30 JAN 26, you can compare the effects of market volatilities on Procter Gamble and ACGCAP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procter Gamble with a short position of ACGCAP. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procter Gamble and ACGCAP.
Diversification Opportunities for Procter Gamble and ACGCAP
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Procter and ACGCAP is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Procter Gamble and ACGCAP 195 30 JAN 26 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACGCAP 195 30 and Procter Gamble is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procter Gamble are associated (or correlated) with ACGCAP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACGCAP 195 30 has no effect on the direction of Procter Gamble i.e., Procter Gamble and ACGCAP go up and down completely randomly.
Pair Corralation between Procter Gamble and ACGCAP
Allowing for the 90-day total investment horizon Procter Gamble is expected to generate 0.91 times more return on investment than ACGCAP. However, Procter Gamble is 1.1 times less risky than ACGCAP. It trades about 0.05 of its potential returns per unit of risk. ACGCAP 195 30 JAN 26 is currently generating about 0.01 per unit of risk. If you would invest 14,509 in Procter Gamble on September 2, 2024 and sell it today you would earn a total of 3,417 from holding Procter Gamble or generate 23.55% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 67.54% |
Values | Daily Returns |
Procter Gamble vs. ACGCAP 195 30 JAN 26
Performance |
Timeline |
Procter Gamble |
ACGCAP 195 30 |
Procter Gamble and ACGCAP Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Procter Gamble and ACGCAP
The main advantage of trading using opposite Procter Gamble and ACGCAP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procter Gamble position performs unexpectedly, ACGCAP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACGCAP will offset losses from the drop in ACGCAP's long position.Procter Gamble vs. Colgate Palmolive | Procter Gamble vs. Unilever PLC ADR | Procter Gamble vs. Kimberly Clark | Procter Gamble vs. Estee Lauder Companies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Bonds Directory Find actively traded corporate debentures issued by US companies |